Biotechnology
14 patents · All ptab
- US100360120 cases6/8 sections
A concise summary of US patent 10036012 is provided below: US Patent 10036012 Summary Title: Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation Assignee: Tecan Genomics Inc…
View full analysis →added 6/15/2026
- Claims invalidated1
- Claims sustained1
- US103370010 cases6/8 sections
Patent Summary: US10337001 - Guide RNA with chemical modifications Title: Guide RNA with chemical modifications Assignee: Agilent Technologies Inc. Inventors: Daniel E. Ryan, Douglas J. Dellinger, Jeffrey R. Sampson, Robert Kaiser, Joel…
View full analysis →added 6/15/2026
- US107601270 cases6/8 sections
Here is a concise summary of US Patent 10760127: Title: Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing Assignee: University of Washington Center for Commercialization Inventors…
View full analysis →added 6/15/2026
- US109000340 cases6/8 sections
US Patent 10,900,034 Summary Title: Guide RNA with chemical modifications Assignee: Agilent Technologies Inc. Inventors: Daniel E. Ryan, Douglas J. Dellinger, Jeffrey R. Sampson, Robert Kaiser, Joel Myerson Filing Date: December 3, 2015…
View full analysis →added 6/15/2026
- US110983570 cases6/8 sections
US Patent 11098357: Compositions and methods for identification of a duplicate sequencing read Assignee: Tecan Genomics Inc Inventors: Douglas A. Amorese, Jonathan Scolnick, Ben Schroeder Filing Date: 2020-01-15 Issue Date: 2021-08-24…
View full analysis →added 6/15/2026
- Claims invalidated2
- US112363180 cases6/8 sections
Summary of U.S. Patent No. 11,236,318 (US11236318B2) Search caveat: My searches of USPTO/PTAB records returned data on this patent and the related PTAB proceeding IPR2025-00440, but no CAFC (Federal Circuit) 2026 docket entry for this…
View full analysis →added 9/9/2026
- US118407300 cases6/8 sections
US Patent 11840730 Summary: Title: Methods and compositions for evaluating genetic markers [cite: https://patents.google.com/patent/US11840730/en] Current Assignee: Molecular Loop Innovations LLC [cite…
View full analysis →added 6/15/2026
- US118966750 cases6/8 sections
US Patent 11896675, titled "Site-specific antibody conjugation and antibody-drug conjugate as specific embodiment thereof," was issued to Abtis Co Ltd (currently listed as Atbis Co Ltd and Abtis Co Ltd) on February 13, 2024. The inventors…
View full analysis →added 8/4/2026
- US119268590 cases6/8 sections
US Patent 11,926,859, titled "Methods and means for the production of Ig-like molecules," was issued on March 12, 2024, from an application filed on May 16, 2023. The current assignee is Merus BV. The inventors are Cornelis Adriaan De…
View full analysis →added 7/9/2026
- US120496520 cases6/8 sections
I'll research US 12049652 using the authoritative patent text provided and live searches for litigation/docket status. Let me get the specific claim text and any 2026 CAFC activity. Let me find the full claim set (independent claims) of…
View full analysis →added 9/26/2026
- US120916920 cases6/8 sections
I'll search for docket and litigation information on this specific patent number, then compile the summary from the authoritative patent text I have. Let me dig into the claims, the PTAB proceeding, and any Federal Circuit activity. I have…
View full analysis →added 9/26/2026
- US121041850 cases6/8 sections
I'll search for authoritative information on this specific patent number. Let me get the specific claim text and PTAB/litigation status for this exact patent. Let me retrieve the exact independent claim language from the patent. US Patent…
View full analysis →added 9/26/2026
- US121105200 cases6/8 sections
I'll verify the CAFC docket and USPTO record for this specific patent number, then summarize. Now let me check specifically for any CAFC appeal docketed from PGR2025-00017 and confirm the patent's bibliographic data. Let me run one more…
View full analysis →added 9/2/2026
- US93582860 cases6/8 sections
US Patent 9358286, titled "Methods and means for the production of IG-like molecules," was issued on June 7, 2016, from an application filed on November 15, 2013. The original and current assignee is Merus BV. The inventors are Cornelis A…
View full analysis →added 7/9/2026